Rekord LOINC: 84891-1
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
84891-1
FHIR
|
| Long Common Name: | Tumor response to neoadjuvant therapy |
| Short Name: | Tumor resp to neoadjvt therapy |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
EN
Oryginalna wersja angielska
Response to neoadjuvant therapy
:
PrThr
:
Pt
:
Colorectal cancer specimen
:
Ord
:
-
Klasyfikacja
| Class: |
ENPATH
|
| Consumer Name: | - |
| Order/Observation: | Observation |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.71 |
Definicja i opis
EN
The response of the tumor to neoadjuvant treatment, such as chemotherapy and radiotherapy. Chemotherapy and/or radiotherapy before resection is associated with significant downstaging and improved prognosis. These specimens require close gross examination and additional blocking to demonstrate tumor. The degree of tumor regression has been shown to correlate with prognosis. This term was created for, but not limited in use to, the Colorectal Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College of Pathologists of Australasia (RCPA).
Powiązane nazwy
CA; Ca spec; CRC spec; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Resp to neoadjvt therapy; Screen; Spec